pbac.pbs.gov.au
Open in
urlscan Pro
103.127.18.21
Public Scan
Submitted URL: http://pbac.pbs.gov.au/
Effective URL: https://pbac.pbs.gov.au/
Submission: On November 08 via api from US — Scanned from AU
Effective URL: https://pbac.pbs.gov.au/
Submission: On November 08 via api from US — Scanned from AU
Form analysis
1 forms found in the DOMName: sform — GET /search.html
<form id="search" name="sform" action="/search.html" method="get" class="navbar-search visible-desktop input-append"><label for="searchinput" class="visuallyhidden">Search</label><input type="text" id="searchinput" name="term" value=""
class="search span3 ui-autocomplete-input" placeholder="Search the PBAC Guidelines" accesskey="5" alt="Search the PBAC Guidelines" required="" autocomplete="off"><button type="submit" class="btn"><i class="icon-search"></i><span
class="visuallyhidden">Search</span></button></form>
Text Content
Skip to navigationSkip to content * Version 5.0 * About the Guidelines * Table of Contents SearchSearch * Home * PBAC Information About the Guidelines Contents * Submission structure for submissions requiring evaluation Submission executive summary Section 1 Context Section 2 Clinical evaluation Section 3 Economic evaluation Section 3A Cost-effectiveness analysis Section 3B Cost minimisation Section 4 Use of the medicine in practice Section 5 Options to present additional relevant information * Requests for Product Types Product type 1 – Fixed-dose combination products Product type 2 – Nutritional products Product type 3 – Vaccine products Product type 4 – Codependent technologies * Appendixes Appendix 1 Expert opinion Appendix 2 Literature search methods Appendix 3 Identify relevant trials Appendix 4 Heterogeneity of treatment effect across studies Appendix 5 Translating comparative treatment effects of proposed surrogate measures to target clinical outcomes 194 Introduction Appendix 6 Including nonhealth outcomes in a supplementary analysis * Contacts GUIDELINES FOR PREPARING SUBMISSIONS TO THE PHARMACEUTICAL BENEFITS ADVISORY COMMITTEE (PBAC) VERSION 5.0 SEPTEMBER 2016 The PBAC Guidelines explain in detail how to prepare a submission to list a new medicine or medicinal product on the Pharmaceutical Benefits Schedule (ie for public funding). The guidelines provide detailed instructions on what information is required by the PBAC and the Economic Sub-Committee (ESC) to support a proposed new medicine, and the most appropriate form of clinical evidence and economic evaluation for specific submissions. Whilst submissions to the PBAC will now need to follow the guidance provided in the PBAC Guidelines version 5.0, the PBAC has approved a transitional arrangement of two PBAC cycles in regard to the structure of submissions. That is, submissions to the PBAC for consideration at either the March or July 2017 PBAC meetings may follow the structure of either version 4.5 or version 5.0 of the Guidelines. Submissions for consideration at the November 2017 meeting must follow the structure of version 5.0 of the PBAC Guidelines. For information on processes, procedures, timelines and documents required, refer to the Procedure guidance for listing medicines on the Pharmaceutical Benefits Scheme. SUBMISSION STRUCTURE FOR SUBMISSIONS REQUIRING EVALUATION PBAC HELP CENTRE FOR MAKING A SUBMISSION DOWNLOADS Printable version of PBAC guidelines Checklists, Templates & Workbooks Utilisation and cost model workbook Forms INFORMATION Product type 1 – Fixed-dose combination products Product type 2 – Nutritional products Product type 3 – Vaccine products Product type 4 – Codependent technologies APPENDIXES Appendix 1 Expert opinion Appendix 2 Literature search methods Appendix 3 Identify relevant trials Appendix 4 Heterogeneity of treatment effect across studies Appendix 5 Translating comparative treatment effects of proposed surrogate measures to target clinical outcomes Appendix 6 Including nonhealth outcomes in a supplementary analysis CONTACT Enquiries about PBAC submissions can be mailed or emailed to the Pharmaceutical Evaluation Branch at the following address: Pharmaceutical Evaluation Branch MDP 910 Department of Health and Aged Care GPO Box 9848 Canberra ACT 2601 Email: PBAC@health.gov.au DEPARTMENT OF HEALTH AND AGED CARE Department of Health and Ageing PBAC GUIDELINES © Commonwealth of Australia ABN: 83 605 426 759 USEFUL LINKS * Glossary of terms * PBAC Manual * PBAC Meetings * Listing Unit Requirements * PBS Calendar * PBS.gov.au Website PBAC INFORMATION * Abbreviations and acronyms * Flowcharts and figures * Document table * Tables SUBMISSION STRUCTURE FOR SUBMISSIONS REQUIRING EVALUATION * Submission executive summary * Section 1 * Section 2 * Section 3 * Section 3A * Section 3B * Section 4 * Section 5 REQUESTS FOR PRODUCT TYPES * Product type 1 * Product type 2 * Product type 3 * Product type 4 APPENDIXES * Appendix 1 * Appendix 2 * Appendix 3 * Appendix 4 * Appendix 5 * Appendix 6 * Printable versions * Contacts * Forms